Hepatitis Forums

Hepatitis C Main Forums => Hepatitis C and HIV Coinfection => Topic started by: Hep Editors on June 22, 2018, 10:36:50 am

Title: Epclusa Cures Hepatitis C at a High Rate Regardless of HIV Status
Post by: Hep Editors on June 22, 2018, 10:36:50 am
Gilead Sciences’ Epclusa (sofosbuvir/velpatasvir) boasted near-perfect hepatitis C virus (HCV) cure rates among both those with and without HIV in a recent study.

Publishing their findings in Alimentary Pharmacology & Therapeutics, researchers conducted a study of 12 weeks of a generic version of Epclusa with or without ribavirin among 69 people coinfected with HIV and HCV and 159 people monoinfected with HCV.

Read more...
https://www.hepmag.com/article/epclusa-cures-hepatitis-c-high-rate-regardless-hiv-status